SUBSCRIBE
SUBSCRIBE

Diagnostics

Policy
Biopharma Update on the Novel Coronavirus: August 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 31, 2020.
August 31, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 26, 2020.
August 25, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: August 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 24, 2020.
August 24, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 21
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 21, 2020.
August 20, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 19, 2020.
August 17, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.
August 17, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: August 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 14, 2020.
August 13, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
August 11, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: August 10
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 10, 2020.
August 10, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Genentech’s Investigational UC Treatment Posts Mixed Results in Late-Stage Studies
A Genentech investigational ulcerative colitis treatment etrolizumab posted mixed results in its late-stage study program in patients who have moderate or severe active forms of the disease.
August 10, 2020
 · 
2 min read
 · 
Alex Keown
Load More
PRESS RELEASES
Press Releases
CorVista Health and ATSS Sign Memorandum of Understanding to Bring Point-of-Care Cardiovascular Diagnostic Platform CorVista® System to the Kingdom of Saudi Arabia
November 13, 2024
 · 
3 min read
Press Releases
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
 · 
12 min read
Press Releases
Stephen R. La Neve joins Insight Medbotics’ Board of Directors
November 12, 2024
 · 
1 min read
Press Releases
Bracco Diagnostics Inc. Obtains Hallmark Achievement of One Million Injections with its MRI agent VUEWAY® (gadopiclenol) solution for injection
November 12, 2024
 · 
7 min read
Press Releases
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
November 11, 2024
 · 
10 min read
Press Releases
BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare Conferences
November 11, 2024
 · 
5 min read
Press Releases
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
November 8, 2024
 · 
8 min read
Press Releases
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
November 8, 2024
 · 
5 min read
Press Releases
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 8, 2024
 · 
1 min read
Press Releases
Teknova Reports Third Quarter 2024 Financial Results
November 8, 2024
 · 
15 min read
Press Releases
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
November 8, 2024
 · 
13 min read
Press Releases
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
November 8, 2024
 · 
7 min read
Press Releases
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
November 7, 2024
 · 
3 min read
Press Releases
Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls
November 7, 2024
 · 
4 min read
Press Releases
Meridian Bioscience Wins the CDC’s Lead Detect Prize Competition, Building on Decades of Leadership in Blood Lead Testing at the Point of Care
November 7, 2024
 · 
4 min read
Press Releases
OraSure Reports Q3 ’24 Revenue of $39.9 Million
November 7, 2024
 · 
23 min read
Press Releases
Precipio Announces Q3-2024 Shareholder Update Call
November 7, 2024
 · 
3 min read
Press Releases
Approx. USD 4.0 M Invested in Product Development for NTDs - GHIT’s First Investment in the Development of Diagnostics for Trachoma
November 7, 2024
 · 
12 min read
Press Releases
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
November 6, 2024
 · 
5 min read
Press Releases
Esaote Group expands production in India
November 6, 2024
 · 
2 min read
Load More